2-Methyl-6-fluoroquinoxaline → 6-Fluoro-2-(4-trimethylsilanyl-but-3-ynyl)-quinoxaline

HRID 422386Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 422386
[F:1][C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[C:7]([CH3:12])[CH:6]=[N:5]2.FC1[C:15]([CH:24]([CH2:27][Si:28]([CH3:31])([CH3:30])[CH3:29])CC)=NC2C(N=1)=CC=CC=2>>[F:1][C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[C:7]([CH2:12][CH2:15][C:24]#[C:27][Si:28]([CH3:31])([CH3:30])[CH3:29])[CH:6]=[N:5]2

Komponenten

3

Versuchsvorschrift

The title compound was prepared in accordance with the general method of Example 118(A), from 6-fluoro-2-methyl-quinoxaline (100 mg, 0.62 mmol). The crude residue was purified by flash chromatography (cyclohexane/AcOEt 4:1) to yield 66 mg (0.24 mmol, 39%) of 6 fluoro-2-(4-trimethylsilanyl-but-3-yl)-quinoxaline as an orange oil.

Aufarbeitung

  1. customThe crude residue was purified by flash chromatography (cyclohexane/AcOEt 4:1)

Quellen und Nachweise

ORD-Eintrag
ord-9e4cc201c2c14de88a47b86b9336f654
Quelldatensatz
uspto-grants-2012_01
Patentnummer
US08101637B2

Notizen zur Reaktion

Wird geladen…